AI In Drug Repurposing Market Trends, Industry Share, Global Report, 2025-2034

Table of Contents

1. Introduction
        1.1. Report Description
            1.1.1.  Objectives of the Study
            1.1.2.  Market Scope
            1.1.3.  Assumptions
        1.2. Stakeholders
    2. Executive Summary
        2.1. Market Highlights
    3. Research Methodology
        3.1. Overview
            3.1.1.  Data Mining
        3.2. Data Sources
            3.2.1.  Primary Sources
            3.2.2.  Secondary Sources
    4. Global AI In Drug Repurposing Market Insights
        4.1. AI In Drug Repurposing Market – Market Snapshot
        4.2. AI In Drug Repurposing Market Dynamics
            4.2.1.  Drivers and Opportunities
                4.2.1.1. Growing Prevalence of Chronic and Rare Diseases Driving Drug Repositioning Efforts: 
                4.2.1.2. Advancements in Machine Learning Enabling Accurate Drug-Target Predictions: 
            4.2.2.  Restraints and Challenges
                4.2.2.1. High Implementation Cost
        4.3. Porter’s Five Forces Analysis
            4.3.1.  Bargaining Power of Suppliers (Moderate)
            4.3.2.  Threats of New Entrants: (Low)
            4.3.3.  Bargaining Power of Buyers (Moderate)
            4.3.4.  Threat of Substitute (Moderate)
            4.3.5.  Rivalry among existing firms (High)
        4.4. PESTEL Analysis
        4.5. AI In Drug Repurposing Market Trends
        4.6. Value Chain Analysis
    5. Global AI In Drug Repurposing Market, by Drug Type
        5.1. Key Findings
        5.2. Introduction
            5.2.1. Global AI In Drug Repurposing Market, by Drug Type, 2020-2034 (USD Billion)
        5.3. Small Molecules
            5.3.1. Global AI In Drug Repurposing Market, by Small Molecules, by Region, 2020-2034 (USD Billion)
        5.4. Biologics
            5.4.1. Global AI In Drug Repurposing Market, by Biologics, by Region, 2020-2034 (USD Billion)
        5.5. Vaccines
            5.5.1. Global AI In Drug Repurposing Market, by Vaccines, by Region, 2020-2034 (USD Billion)
        5.6. Peptides
            5.6.1. Global AI In Drug Repurposing Market, by Peptides, by Region, 2020-2034 (USD Billion)
        5.7. Others
            5.7.1. Global AI In Drug Repurposing Market, by Others, by Region, 2020-2034 (USD Billion)
    6. Global AI In Drug Repurposing Market, by Therapeutic Area
        6.1. Key Findings
        6.2. Introduction
            6.2.1. Global AI In Drug Repurposing Market, by Therapeutic Area, 2020-2034 (USD Billion)
        6.3. Oncology
            6.3.1. Global AI In Drug Repurposing Market, by Oncology, by Region, 2020-2034 (USD Billion)
        6.4. Neurology
            6.4.1. Global AI In Drug Repurposing Market, by Neurology, by Region, 2020-2034 (USD Billion)
        6.5. Cardiovascular Diseases
            6.5.1. Global AI In Drug Repurposing Market, by Cardiovascular Diseases, by Region, 2020-2034 (USD Billion)
        6.6. Infectious Diseases
            6.6.1. Global AI In Drug Repurposing Market, by Infectious Diseases, by Region, 2020-2034 (USD Billion)
        6.7. Immunology
            6.7.1. Global AI In Drug Repurposing Market, by Immunology, by Region, 2020-2034 (USD Billion)
        6.8. Metabolic Disorders
            6.8.1. Global AI In Drug Repurposing Market, by Metabolic Disorders, by Region, 2020-2034 (USD Billion)
        6.9. Rare Diseases
            6.9.1. Global AI In Drug Repurposing Market, by Rare Diseases, by Region, 2020-2034 (USD Billion)
        6.10. Others
            6.10.1. Global AI In Drug Repurposing Market, by Others, by Region, 2020-2034 (USD Billion)
    7. Global AI In Drug Repurposing Market, by Deployment Mode
        7.1. Key Findings
        7.2. Introduction
            7.2.1. Global AI In Drug Repurposing Market, by Deployment Mode, 2020-2034 (USD Billion)
        7.3. Cloud-based
            7.3.1. Global AI In Drug Repurposing Market, by Cloud-based, by Region, 2020-2034 (USD Billion)
        7.4. On-premises
            7.4.1. Global AI In Drug Repurposing Market, by On-premises, by Region, 2020-2034 (USD Billion)
    8. Global AI In Drug Repurposing Market, by End-user
        8.1. Key Findings
        8.2. Introduction
            8.2.1. Global AI In Drug Repurposing Market, by End-user, 2020-2034 (USD Billion)
        8.3. Pharmaceutical & Biotechnology Companies
            8.3.1. Global AI In Drug Repurposing Market, by Pharmaceutical & Biotechnology Companies, by Region, 2020-2034 (USD Billion)
        8.4. Contract Research Organizations (CROs)
            8.4.1. Global AI In Drug Repurposing Market, by Contract Research Organizations (CROs), by Region, 2020-2034 (USD Billion)
        8.5. Academic & Research Institutes
            8.5.1. Global AI In Drug Repurposing Market, by Academic & Research Institutes, by Region, 2020-2034 (USD Billion)
        8.6. Healthcare Providers
            8.6.1. Global AI In Drug Repurposing Market, by Healthcare Providers, by Region, 2020-2034 (USD Billion)
        8.7. Others
            8.7.1. Global AI In Drug Repurposing Market, by Others, by Region, 2020-2034 (USD Billion)
    9. Global AI In Drug Repurposing Market, by Geography
        9.1. Key Findings
        9.2. Introduction
            9.2.1. AI In Drug Repurposing Market Assessment, By Geography, 2020-2034 (USD Billion)
        9.3. AI In Drug Repurposing Market – North America
            9.3.1. North America: AI In Drug Repurposing Market, by Drug Type, 2020-2034 (USD Billion)
            9.3.2. North America: AI In Drug Repurposing Market, by Therapeutic Area, 2020-2034 (USD Billion)
            9.3.3. North America: AI In Drug Repurposing Market, by Deployment Mode, 2020-2034 (USD Billion)
            9.3.4. North America: AI In Drug Repurposing Market, by End-user, 2020-2034 (USD Billion)
            9.3.5. AI In Drug Repurposing Market – U.S.
                9.3.5.1. U.S.: AI In Drug Repurposing Market, by Drug Type, 2020-2034 (USD Billion)
                9.3.5.2. U.S.: AI In Drug Repurposing Market, by Therapeutic Area, 2020-2034 (USD Billion)
                9.3.5.3. U.S.: AI In Drug Repurposing Market, by Deployment Mode, 2020-2034 (USD Billion)
                9.3.5.4. U.S.: AI In Drug Repurposing Market, by End-user, 2020-2034 (USD Billion)
            9.3.6. AI In Drug Repurposing Market – Canada
                9.3.6.1. Canada: AI In Drug Repurposing Market, by Drug Type, 2020-2034 (USD Billion)
                9.3.6.2. Canada: AI In Drug Repurposing Market, by Therapeutic Area, 2020-2034 (USD Billion)
                9.3.6.3. Canada: AI In Drug Repurposing Market, by Deployment Mode, 2020-2034 (USD Billion)
                9.3.6.4. Canada: AI In Drug Repurposing Market, by End-user, 2020-2034 (USD Billion)
        9.4. AI In Drug Repurposing Market – Europe
            9.4.1. Europe: AI In Drug Repurposing Market, by Drug Type, 2020-2034 (USD Billion)
            9.4.2. Europe: AI In Drug Repurposing Market, by Therapeutic Area, 2020-2034 (USD Billion)
            9.4.3. Europe: AI In Drug Repurposing Market, by Deployment Mode, 2020-2034 (USD Billion)
            9.4.4. Europe: AI In Drug Repurposing Market, by End-user, 2020-2034 (USD Billion)
            9.4.5. AI In Drug Repurposing Market – UK
                9.4.5.1. UK: AI In Drug Repurposing Market, by Drug Type, 2020-2034 (USD Billion)
                9.4.5.2. UK: AI In Drug Repurposing Market, by Therapeutic Area, 2020-2034 (USD Billion)
                9.4.5.3. UK: AI In Drug Repurposing Market, by Deployment Mode, 2020-2034 (USD Billion)
                9.4.5.4. UK: AI In Drug Repurposing Market, by End-user, 2020-2034 (USD Billion)
            9.4.6. AI In Drug Repurposing Market – France
                9.4.6.1. France: AI In Drug Repurposing Market, by Drug Type, 2020-2034 (USD Billion)
                9.4.6.2. France: AI In Drug Repurposing Market, by Therapeutic Area, 2020-2034 (USD Billion)
                9.4.6.3. France: AI In Drug Repurposing Market, by Deployment Mode, 2020-2034 (USD Billion)
                9.4.6.4. France: AI In Drug Repurposing Market, by End-user, 2020-2034 (USD Billion)
            9.4.7. AI In Drug Repurposing Market – Germany
                9.4.7.1. Germany: AI In Drug Repurposing Market, by Drug Type, 2020-2034 (USD Billion)
                9.4.7.2. Germany: AI In Drug Repurposing Market, by Therapeutic Area, 2020-2034 (USD Billion)
                9.4.7.3. Germany: AI In Drug Repurposing Market, by Deployment Mode, 2020-2034 (USD Billion)
                9.4.7.4. Germany: AI In Drug Repurposing Market, by End-user, 2020-2034 (USD Billion)
            9.4.8. AI In Drug Repurposing Market – Italy
                9.4.8.1. Italy: AI In Drug Repurposing Market, by Drug Type, 2020-2034 (USD Billion)
                9.4.8.2. Italy: AI In Drug Repurposing Market, by Therapeutic Area, 2020-2034 (USD Billion)
                9.4.8.3. Italy: AI In Drug Repurposing Market, by Deployment Mode, 2020-2034 (USD Billion)
                9.4.8.4. Italy: AI In Drug Repurposing Market, by End-user, 2020-2034 (USD Billion)
            9.4.9. AI In Drug Repurposing Market – Spain
                9.4.9.1. Spain: AI In Drug Repurposing Market, by Drug Type, 2020-2034 (USD Billion)
                9.4.9.2. Spain: AI In Drug Repurposing Market, by Therapeutic Area, 2020-2034 (USD Billion)
                9.4.9.3. Spain: AI In Drug Repurposing Market, by Deployment Mode, 2020-2034 (USD Billion)
                9.4.9.4. Spain: AI In Drug Repurposing Market, by End-user, 2020-2034 (USD Billion)
            9.4.10. AI In Drug Repurposing Market – Netherlands
                9.4.10.1. Netherlands: AI In Drug Repurposing Market, by Drug Type, 2020-2034 (USD Billion)
                9.4.10.2. Netherlands: AI In Drug Repurposing Market, by Therapeutic Area, 2020-2034 (USD Billion)
                9.4.10.3. Netherlands: AI In Drug Repurposing Market, by Deployment Mode, 2020-2034 (USD Billion)
                9.4.10.4. Netherlands: AI In Drug Repurposing Market, by End-user, 2020-2034 (USD Billion)
            9.4.11. AI In Drug Repurposing Market – Russia
                9.4.11.1. Russia: AI In Drug Repurposing Market, by Drug Type, 2020-2034 (USD Billion)
                9.4.11.2. Russia: AI In Drug Repurposing Market, by Therapeutic Area, 2020-2034 (USD Billion)
                9.4.11.3. Russia: AI In Drug Repurposing Market, by Deployment Mode, 2020-2034 (USD Billion)
                9.4.11.4. Russia: AI In Drug Repurposing Market, by End-user, 2020-2034 (USD Billion)
            9.4.12. AI In Drug Repurposing Market – Rest of Europe
                9.4.12.1. Rest of Europe: AI In Drug Repurposing Market, by Drug Type, 2020-2034 (USD Billion)
                9.4.12.2. Rest of Europe: AI In Drug Repurposing Market, by Therapeutic Area, 2020-2034 (USD Billion)
                9.4.12.3. Rest of Europe: AI In Drug Repurposing Market, by Deployment Mode, 2020-2034 (USD Billion)
                9.4.12.4. Rest of Europe: AI In Drug Repurposing Market, by End-user, 2020-2034 (USD Billion)
        9.5. AI In Drug Repurposing Market – Asia Pacific
            9.5.1. Asia Pacific: AI In Drug Repurposing Market, by Drug Type, 2020-2034 (USD Billion)
            9.5.2. Asia Pacific: AI In Drug Repurposing Market, by Therapeutic Area, 2020-2034 (USD Billion)
            9.5.3. Asia Pacific: AI In Drug Repurposing Market, by Deployment Mode, 2020-2034 (USD Billion)
            9.5.4. Asia Pacific: AI In Drug Repurposing Market, by End-user, 2020-2034 (USD Billion)
            9.5.5. AI In Drug Repurposing Market – China
                9.5.5.1. China: AI In Drug Repurposing Market, by Drug Type, 2020-2034 (USD Billion)
                9.5.5.2. China: AI In Drug Repurposing Market, by Therapeutic Area, 2020-2034 (USD Billion)
                9.5.5.3. China: AI In Drug Repurposing Market, by Deployment Mode, 2020-2034 (USD Billion)
                9.5.5.4. China: AI In Drug Repurposing Market, by End-user, 2020-2034 (USD Billion)
            9.5.6. AI In Drug Repurposing Market – India
                9.5.6.1. India: AI In Drug Repurposing Market, by Drug Type, 2020-2034 (USD Billion)
                9.5.6.2. India: AI In Drug Repurposing Market, by Therapeutic Area, 2020-2034 (USD Billion)
                9.5.6.3. India: AI In Drug Repurposing Market, by Deployment Mode, 2020-2034 (USD Billion)
                9.5.6.4. India: AI In Drug Repurposing Market, by End-user, 2020-2034 (USD Billion)
            9.5.7. AI In Drug Repurposing Market – Malaysia
                9.5.7.1. Malaysia: AI In Drug Repurposing Market, by Drug Type, 2020-2034 (USD Billion)
                9.5.7.2. Malaysia: AI In Drug Repurposing Market, by Therapeutic Area, 2020-2034 (USD Billion)
                9.5.7.3. Malaysia: AI In Drug Repurposing Market, by Deployment Mode, 2020-2034 (USD Billion)
                9.5.7.4. Malaysia: AI In Drug Repurposing Market, by End-user, 2020-2034 (USD Billion)
            9.5.8. AI In Drug Repurposing Market – Japan
                9.5.8.1. Japan: AI In Drug Repurposing Market, by Drug Type, 2020-2034 (USD Billion)
                9.5.8.2. Japan: AI In Drug Repurposing Market, by Therapeutic Area, 2020-2034 (USD Billion)
                9.5.8.3. Japan: AI In Drug Repurposing Market, by Deployment Mode, 2020-2034 (USD Billion)
                9.5.8.4. Japan: AI In Drug Repurposing Market, by End-user, 2020-2034 (USD Billion)
            9.5.9. AI In Drug Repurposing Market – Indonesia
                9.5.9.1. Indonesia: AI In Drug Repurposing Market, by Drug Type, 2020-2034 (USD Billion)
                9.5.9.2. Indonesia: AI In Drug Repurposing Market, by Therapeutic Area, 2020-2034 (USD Billion)
                9.5.9.3. Indonesia: AI In Drug Repurposing Market, by Deployment Mode, 2020-2034 (USD Billion)
                9.5.9.4. Indonesia: AI In Drug Repurposing Market, by End-user, 2020-2034 (USD Billion)
            9.5.10. AI In Drug Repurposing Market – South Korea
                9.5.10.1. South Korea: AI In Drug Repurposing Market, by Drug Type, 2020-2034 (USD Billion)
                9.5.10.2. South Korea: AI In Drug Repurposing Market, by Therapeutic Area, 2020-2034 (USD Billion)
                9.5.10.3. South Korea: AI In Drug Repurposing Market, by Deployment Mode, 2020-2034 (USD Billion)
                9.5.10.4. South Korea: AI In Drug Repurposing Market, by End-user, 2020-2034 (USD Billion)
            9.5.11. AI In Drug Repurposing Market – Australia
                9.5.11.1. Australia: AI In Drug Repurposing Market, by Drug Type, 2020-2034 (USD Billion)
                9.5.11.2. Australia: AI In Drug Repurposing Market, by Therapeutic Area, 2020-2034 (USD Billion)
                9.5.11.3. Australia: AI In Drug Repurposing Market, by Deployment Mode, 2020-2034 (USD Billion)
                9.5.11.4. Australia: AI In Drug Repurposing Market, by End-user, 2020-2034 (USD Billion)
            9.5.12. AI In Drug Repurposing Market – Rest of Asia Pacific
                9.5.12.1. Rest of Asia Pacific: AI In Drug Repurposing Market, by Drug Type, 2020-2034 (USD Billion)
                9.5.12.2. Rest of Asia Pacific: AI In Drug Repurposing Market, by Therapeutic Area, 2020-2034 (USD Billion)
                9.5.12.3. Rest of Asia Pacific: AI In Drug Repurposing Market, by Deployment Mode, 2020-2034 (USD Billion)
                9.5.12.4. Rest of Asia Pacific: AI In Drug Repurposing Market, by End-user, 2020-2034 (USD Billion)
        9.6. AI In Drug Repurposing Market – Middle East & Africa
            9.6.1. Middle East & Africa: AI In Drug Repurposing Market, by Drug Type, 2020-2034 (USD Billion)
            9.6.2. Middle East & Africa: AI In Drug Repurposing Market, by Therapeutic Area, 2020-2034 (USD Billion)
            9.6.3. Middle East & Africa: AI In Drug Repurposing Market, by Deployment Mode, 2020-2034 (USD Billion)
            9.6.4. Middle East & Africa: AI In Drug Repurposing Market, by End-user, 2020-2034 (USD Billion)
            9.6.5. AI In Drug Repurposing Market – Saudi Arabia
                9.6.5.1. Saudi Arabia: AI In Drug Repurposing Market, by Drug Type, 2020-2034 (USD Billion)
                9.6.5.2. Saudi Arabia: AI In Drug Repurposing Market, by Therapeutic Area, 2020-2034 (USD Billion)
                9.6.5.3. Saudi Arabia: AI In Drug Repurposing Market, by Deployment Mode, 2020-2034 (USD Billion)
                9.6.5.4. Saudi Arabia: AI In Drug Repurposing Market, by End-user, 2020-2034 (USD Billion)
            9.6.6. AI In Drug Repurposing Market – UAE
                9.6.6.1. UAE: AI In Drug Repurposing Market, by Drug Type, 2020-2034 (USD Billion)
                9.6.6.2. UAE: AI In Drug Repurposing Market, by Therapeutic Area, 2020-2034 (USD Billion)
                9.6.6.3. UAE: AI In Drug Repurposing Market, by Deployment Mode, 2020-2034 (USD Billion)
                9.6.6.4. UAE: AI In Drug Repurposing Market, by End-user, 2020-2034 (USD Billion)
            9.6.7. AI In Drug Repurposing Market – Israel
                9.6.7.1. Israel: AI In Drug Repurposing Market, by Drug Type, 2020-2034 (USD Billion)
                9.6.7.2. Israel: AI In Drug Repurposing Market, by Therapeutic Area, 2020-2034 (USD Billion)
                9.6.7.3. Israel: AI In Drug Repurposing Market, by Deployment Mode, 2020-2034 (USD Billion)
                9.6.7.4. Israel: AI In Drug Repurposing Market, by End-user, 2020-2034 (USD Billion)
            9.6.8. AI In Drug Repurposing Market – South Africa
                9.6.8.1. South Africa: AI In Drug Repurposing Market, by Drug Type, 2020-2034 (USD Billion)
                9.6.8.2. South Africa: AI In Drug Repurposing Market, by Therapeutic Area, 2020-2034 (USD Billion)
                9.6.8.3. South Africa: AI In Drug Repurposing Market, by Deployment Mode, 2020-2034 (USD Billion)
                9.6.8.4. South Africa: AI In Drug Repurposing Market, by End-user, 2020-2034 (USD Billion)
            9.6.9. AI In Drug Repurposing Market – Rest of Middle East & Africa
                9.6.9.1. Rest of Middle East & Africa: AI In Drug Repurposing Market, by Drug Type, 2020-2034 (USD Billion)
                9.6.9.2. Rest of Middle East & Africa: AI In Drug Repurposing Market, by Therapeutic Area, 2020-2034 (USD Billion)
                9.6.9.3. Rest of Middle East & Africa: AI In Drug Repurposing Market, by Deployment Mode, 2020-2034 (USD Billion)
                9.6.9.4. Rest of Middle East & Africa: AI In Drug Repurposing Market, by End-user, 2020-2034 (USD Billion)
        9.7. AI In Drug Repurposing Market – Latin America
            9.7.1. Latin America: AI In Drug Repurposing Market, by Drug Type, 2020-2034 (USD Billion)
            9.7.2. Latin America: AI In Drug Repurposing Market, by Therapeutic Area, 2020-2034 (USD Billion)
            9.7.3. Latin America: AI In Drug Repurposing Market, by Deployment Mode, 2020-2034 (USD Billion)
            9.7.4. Latin America: AI In Drug Repurposing Market, by End-user, 2020-2034 (USD Billion)
            9.7.5. AI In Drug Repurposing Market – Mexico
                9.7.5.1. Mexico: AI In Drug Repurposing Market, by Drug Type, 2020-2034 (USD Billion)
                9.7.5.2. Mexico: AI In Drug Repurposing Market, by Therapeutic Area, 2020-2034 (USD Billion)
                9.7.5.3. Mexico: AI In Drug Repurposing Market, by Deployment Mode, 2020-2034 (USD Billion)
                9.7.5.4. Mexico: AI In Drug Repurposing Market, by End-user, 2020-2034 (USD Billion)
            9.7.6. AI In Drug Repurposing Market – Brazil
                9.7.6.1. Brazil: AI In Drug Repurposing Market, by Drug Type, 2020-2034 (USD Billion)
                9.7.6.2. Brazil: AI In Drug Repurposing Market, by Therapeutic Area, 2020-2034 (USD Billion)
                9.7.6.3. Brazil: AI In Drug Repurposing Market, by Deployment Mode, 2020-2034 (USD Billion)
                9.7.6.4. Brazil: AI In Drug Repurposing Market, by End-user, 2020-2034 (USD Billion)
            9.7.7. AI In Drug Repurposing Market – Argentina
                9.7.7.1. Argentina: AI In Drug Repurposing Market, by Drug Type, 2020-2034 (USD Billion)
                9.7.7.2. Argentina: AI In Drug Repurposing Market, by Therapeutic Area, 2020-2034 (USD Billion)
                9.7.7.3. Argentina: AI In Drug Repurposing Market, by Deployment Mode, 2020-2034 (USD Billion)
                9.7.7.4. Argentina: AI In Drug Repurposing Market, by End-user, 2020-2034 (USD Billion)
            9.7.8. AI In Drug Repurposing Market – Rest of Latin America
                9.7.8.1. Rest of Latin America: AI In Drug Repurposing Market, by Drug Type, 2020-2034 (USD Billion)
                9.7.8.2. Rest of Latin America: AI In Drug Repurposing Market, by Therapeutic Area, 2020-2034 (USD Billion)
                9.7.8.3. Rest of Latin America: AI In Drug Repurposing Market, by Deployment Mode, 2020-2034 (USD Billion)
                9.7.8.4. Rest of Latin America: AI In Drug Repurposing Market, by End-user, 2020-2034 (USD Billion)
    10. Competitive Landscape
        10.1. Expansion and Acquisition Analysis
            10.1.1. Expansion
            10.1.2. Acquisitions
        10.2. Partnerships/Collaborations/Agreements/Exhibitions
    11. Company Profiles
        11.1. Atomwise, Inc.
            11.1.1. Company Overview
            11.1.2. Financial Performance
            11.1.3. Product Benchmarking
            11.1.4. Recent Development
        11.2. BenevolentAI Limited
            11.2.1. Company Overview
            11.2.2. Financial Performance
            11.2.3. Product Benchmarking
            11.2.4. Recent Development
        11.3. BioAge Labs, Inc.
            11.3.1. Company Overview
            11.3.2. Financial Performance
            11.3.3. Product Benchmarking
            11.3.4. Recent Development
        11.4. BioXcel Therapeutics, Inc.
            11.4.1. Company Overview
            11.4.2. Financial Performance
            11.4.3. Product Benchmarking
            11.4.4. Recent Development
        11.5. BostonGene Corporation
            11.5.1. Company Overview
            11.5.2. Financial Performance
            11.5.3. Product Benchmarking
            11.5.4. Recent Development
        11.6. Cyclica Inc.
            11.6.1. Company Overview
            11.6.2. Financial Performance
            11.6.3. Product Benchmarking
            11.6.4. Recent Development
        11.7. Exscientia plc
            11.7.1. Company Overview
            11.7.2. Financial Performance
            11.7.3. Product Benchmarking
            11.7.4. Recent Development
        11.8. Ginkgo Bioworks Holdings, Inc.
            11.8.1. Company Overview
            11.8.2. Financial Performance
            11.8.3. Product Benchmarking
            11.8.4. Recent Development
        11.9. Healx Ltd.
            11.9.1. Company Overview
            11.9.2. Financial Performance
            11.9.3. Product Benchmarking
            11.9.4. Recent Development
        11.10. Ignota Labs Ltd.
            11.10.1. Company Overview
            11.10.2. Financial Performance
            11.10.3. Product Benchmarking
            11.10.4. Recent Development
        11.11. Insilico Medicine, Inc.
            11.11.1. Company Overview
            11.11.2. Financial Performance
            11.11.3. Product Benchmarking
            11.11.4. Recent Development
        11.12. Melior Discovery, Inc.
            11.12.1. Company Overview
            11.12.2. Financial Performance
            11.12.3. Product Benchmarking
            11.12.4. Recent Development

    List of Tables:

    Table 1 Global AI In Drug Repurposing Market, by Drug Type, 2020-2034 (USD Billion)
    Table 2 Global AI In Drug Repurposing Market, by Therapeutic Area, 2020-2034 (USD Billion)
    Table 3 Global AI In Drug Repurposing Market, by Deployment Mode, 2020-2034 (USD Billion)
    Table 4 Global AI In Drug Repurposing Market, by End-user, 2020-2034 (USD Billion)
    Table 5 North America: AI In Drug Repurposing Market, by Drug Type, 2020-2034 (USD Billion)
    Table 6 North America: AI In Drug Repurposing Market, by Therapeutic Area, 2020-2034 (USD Billion)
    Table 7 North America: AI In Drug Repurposing Market, by Deployment Mode, 2020-2034 (USD Billion)
    Table 8 North America: AI In Drug Repurposing Market, by End-user, 2020-2034 (USD Billion)
    Table 9 U.S.: AI In Drug Repurposing Market, by Drug Type, 2020-2034 (USD Billion)
    Table 10 U.S.: AI In Drug Repurposing Market, by Therapeutic Area, 2020-2034 (USD Billion)
    Table 11 U.S.: AI In Drug Repurposing Market, by Deployment Mode, 2020-2034 (USD Billion)
    Table 12 U.S.: AI In Drug Repurposing Market, by End-user, 2020-2034 (USD Billion)
    Table 13 Canada: AI In Drug Repurposing Market, by Drug Type, 2020-2034 (USD Billion)
    Table 14 Canada: AI In Drug Repurposing Market, by Therapeutic Area, 2020-2034 (USD Billion)
    Table 15 Canada: AI In Drug Repurposing Market, by Deployment Mode, 2020-2034 (USD Billion)
    Table 16 Canada: AI In Drug Repurposing Market, by End-user, 2020-2034 (USD Billion)
    Table 17 Europe: AI In Drug Repurposing Market, by Drug Type, 2020-2034 (USD Billion)
    Table 18 Europe: AI In Drug Repurposing Market, by Therapeutic Area, 2020-2034 (USD Billion)
    Table 19 Europe: AI In Drug Repurposing Market, by Deployment Mode, 2020-2034 (USD Billion)
    Table 20 Europe: AI In Drug Repurposing Market, by End-user, 2020-2034 (USD Billion)
    Table 21 UK: AI In Drug Repurposing Market, by Drug Type, 2020-2034 (USD Billion)
    Table 22 UK: AI In Drug Repurposing Market, by Therapeutic Area, 2020-2034 (USD Billion)
    Table 23 UK: AI In Drug Repurposing Market, by Deployment Mode, 2020-2034 (USD Billion)
    Table 24 UK: AI In Drug Repurposing Market, by End-user, 2020-2034 (USD Billion)
    Table 25 France: AI In Drug Repurposing Market, by Drug Type, 2020-2034 (USD Billion)
    Table 26 France: AI In Drug Repurposing Market, by Therapeutic Area, 2020-2034 (USD Billion)
    Table 27 France: AI In Drug Repurposing Market, by Deployment Mode, 2020-2034 (USD Billion)
    Table 28 France: AI In Drug Repurposing Market, by End-user, 2020-2034 (USD Billion)
    Table 29 Germany: AI In Drug Repurposing Market, by Drug Type, 2020-2034 (USD Billion)
    Table 30 Germany: AI In Drug Repurposing Market, by Therapeutic Area, 2020-2034 (USD Billion)
    Table 31 Germany: AI In Drug Repurposing Market, by Deployment Mode, 2020-2034 (USD Billion)
    Table 32 Germany: AI In Drug Repurposing Market, by End-user, 2020-2034 (USD Billion)
    Table 33 Italy: AI In Drug Repurposing Market, by Drug Type, 2020-2034 (USD Billion)
    Table 34 Italy: AI In Drug Repurposing Market, by Therapeutic Area, 2020-2034 (USD Billion)
    Table 35 Italy: AI In Drug Repurposing Market, by Deployment Mode, 2020-2034 (USD Billion)
    Table 36 Italy: AI In Drug Repurposing Market, by End-user, 2020-2034 (USD Billion)
    Table 37 Spain: AI In Drug Repurposing Market, by Drug Type, 2020-2034 (USD Billion)
    Table 38 Spain: AI In Drug Repurposing Market, by Therapeutic Area, 2020-2034 (USD Billion)
    Table 39 Spain: AI In Drug Repurposing Market, by Deployment Mode, 2020-2034 (USD Billion)
    Table 40 Spain: AI In Drug Repurposing Market, by End-user, 2020-2034 (USD Billion)
    Table 41 Netherlands: AI In Drug Repurposing Market, by Drug Type, 2020-2034 (USD Billion)
    Table 42 Netherlands: AI In Drug Repurposing Market, by Therapeutic Area, 2020-2034 (USD Billion)
    Table 43 Netherlands: AI In Drug Repurposing Market, by Deployment Mode, 2020-2034 (USD Billion)
    Table 44 Netherlands: AI In Drug Repurposing Market, by End-user, 2020-2034 (USD Billion)
    Table 45 Russia: AI In Drug Repurposing Market, by Drug Type, 2020-2034 (USD Billion)
    Table 46 Russia: AI In Drug Repurposing Market, by Therapeutic Area, 2020-2034 (USD Billion)
    Table 47 Russia: AI In Drug Repurposing Market, by Deployment Mode, 2020-2034 (USD Billion)
    Table 48 Russia: AI In Drug Repurposing Market, by End-user, 2020-2034 (USD Billion)
    Table 49 Rest of Europe: AI In Drug Repurposing Market, by Drug Type, 2020-2034 (USD Billion)
    Table 50 Rest of Europe: AI In Drug Repurposing Market, by Therapeutic Area, 2020-2034 (USD Billion)
    Table 51 Rest of Europe: AI In Drug Repurposing Market, by Deployment Mode, 2020-2034 (USD Billion)
    Table 52 Rest of Europe: AI In Drug Repurposing Market, by End-user, 2020-2034 (USD Billion)
    Table 53 Asia Pacific: AI In Drug Repurposing Market, by Drug Type, 2020-2034 (USD Billion)
    Table 54 Asia Pacific: AI In Drug Repurposing Market, by Therapeutic Area, 2020-2034 (USD Billion)
    Table 55 Asia Pacific: AI In Drug Repurposing Market, by Deployment Mode, 2020-2034 (USD Billion)
    Table 56 Asia Pacific: AI In Drug Repurposing Market, by End-user, 2020-2034 (USD Billion)
    Table 57 China: AI In Drug Repurposing Market, by Drug Type, 2020-2034 (USD Billion)
    Table 58 China: AI In Drug Repurposing Market, by Therapeutic Area, 2020-2034 (USD Billion)
    Table 59 China: AI In Drug Repurposing Market, by Deployment Mode, 2020-2034 (USD Billion)
    Table 60 China: AI In Drug Repurposing Market, by End-user, 2020-2034 (USD Billion)
    Table 61 India: AI In Drug Repurposing Market, by Drug Type, 2020-2034 (USD Billion)
    Table 62 India: AI In Drug Repurposing Market, by Therapeutic Area, 2020-2034 (USD Billion)
    Table 63 India: AI In Drug Repurposing Market, by Deployment Mode, 2020-2034 (USD Billion)
    Table 64 India: AI In Drug Repurposing Market, by End-user, 2020-2034 (USD Billion)
    Table 65 Malaysia: AI In Drug Repurposing Market, by Drug Type, 2020-2034 (USD Billion)
    Table 66 Malaysia: AI In Drug Repurposing Market, by Therapeutic Area, 2020-2034 (USD Billion)
    Table 67 Malaysia: AI In Drug Repurposing Market, by Deployment Mode, 2020-2034 (USD Billion)
    Table 68  Malaysia: AI In Drug Repurposing Market, by End-user, 2020-2034 (USD Billion)
    Table 69 Japan: AI In Drug Repurposing Market, by Drug Type, 2020-2034 (USD Billion)
    Table 70  Japan: AI In Drug Repurposing Market, by Therapeutic Area, 2020-2034 (USD Billion)
    Table 71  Japan: AI In Drug Repurposing Market, by Deployment Mode, 2020-2034 (USD Billion)
    Table 72  Japan: AI In Drug Repurposing Market, by End-user, 2020-2034 (USD Billion)
    Table 73 Indonesia: AI In Drug Repurposing Market, by Drug Type, 2020-2034 (USD Billion)
    Table 74  Indonesia: AI In Drug Repurposing Market, by Therapeutic Area, 2020-2034 (USD Billion)
    Table 75  Indonesia: AI In Drug Repurposing Market, by Deployment Mode, 2020-2034 (USD Billion)
    Table 76  Indonesia: AI In Drug Repurposing Market, by End-user, 2020-2034 (USD Billion)
    Table 77 South Korea: AI In Drug Repurposing Market, by Drug Type, 2020-2034 (USD Billion)
    Table 78  South Korea: AI In Drug Repurposing Market, by Therapeutic Area, 2020-2034 (USD Billion)
    Table 79  South Korea: AI In Drug Repurposing Market, by Deployment Mode, 2020-2034 (USD Billion)
    Table 80  South Korea: AI In Drug Repurposing Market, by End-user, 2020-2034 (USD Billion)
    Table 81 Australia: AI In Drug Repurposing Market, by Drug Type, 2020-2034 (USD Billion)
    Table 82  Australia: AI In Drug Repurposing Market, by Therapeutic Area, 2020-2034 (USD Billion)
    Table 83  Australia: AI In Drug Repurposing Market, by Deployment Mode, 2020-2034 (USD Billion)
    Table 84  Australia: AI In Drug Repurposing Market, by End-user, 2020-2034 (USD Billion)
    Table 85 Rest of Asia Pacific: AI In Drug Repurposing Market, by Drug Type, 2020-2034 (USD Billion)
    Table 86  Rest of Asia Pacific: AI In Drug Repurposing Market, by Therapeutic Area, 2020-2034 (USD Billion)
    Table 87  Rest of Asia Pacific: AI In Drug Repurposing Market, by Deployment Mode, 2020-2034 (USD Billion)
    Table 88  Rest of Asia Pacific: AI In Drug Repurposing Market, by End-user, 2020-2034 (USD Billion) 
    Table 89 Middle East & Africa: AI In Drug Repurposing Market, by Drug Type, 2020-2034 (USD Billion)
    Table 90  Middle East & Africa: AI In Drug Repurposing Market, by Therapeutic Area, 2020-2034 (USD Billion)
    Table 91  Middle East & Africa: AI In Drug Repurposing Market, by Deployment Mode, 2020-2034 (USD Billion)
    Table 92  Middle East & Africa: AI In Drug Repurposing Market, by End-user, 2020-2034 (USD Billion) 
    Table 93 Saudi Arabia: AI In Drug Repurposing Market, by Drug Type, 2020-2034 (USD Billion)
    Table 94  Saudi Arabia: AI In Drug Repurposing Market, by Therapeutic Area, 2020-2034 (USD Billion)
    Table 95  Saudi Arabia: AI In Drug Repurposing Market, by Deployment Mode, 2020-2034 (USD Billion)
    Table 96  Saudi Arabia: AI In Drug Repurposing Market, by End-user, 2020-2034 (USD Billion)
    Table 97 UAE: AI In Drug Repurposing Market, by Drug Type, 2020-2034 (USD Billion)
    Table 98  UAE: AI In Drug Repurposing Market, by Therapeutic Area, 2020-2034 (USD Billion)
    Table 99  UAE: AI In Drug Repurposing Market, by Deployment Mode, 2020-2034 (USD Billion)
    Table 100  UAE: AI In Drug Repurposing Market, by End-user, 2020-2034 (USD Billion)
    Table 101 Israel: AI In Drug Repurposing Market, by Drug Type, 2020-2034 (USD Billion)
    Table 102  Israel: AI In Drug Repurposing Market, by Therapeutic Area, 2020-2034 (USD Billion)
    Table 103  Israel: AI In Drug Repurposing Market, by Deployment Mode, 2020-2034 (USD Billion)
    Table 104  Israel: AI In Drug Repurposing Market, by End-user, 2020-2034 (USD Billion)
    Table 105 South Africa: AI In Drug Repurposing Market, by Drug Type, 2020-2034 (USD Billion)
    Table 106  South Africa: AI In Drug Repurposing Market, by Therapeutic Area, 2020-2034 (USD Billion)
    Table 107  South Africa: AI In Drug Repurposing Market, by Deployment Mode, 2020-2034 (USD Billion)
    Table 108  South Africa: AI In Drug Repurposing Market, by End-user, 2020-2034 (USD Billion)
    Table 109 Rest of Middle East & Africa: AI In Drug Repurposing Market, by Drug Type, 2020-2034 (USD Billion) 
    Table 110  Rest of Middle East & Africa: AI In Drug Repurposing Market, by Therapeutic Area, 2020-2034 (USD Billion)
    Table 111  Rest of Middle East & Africa: AI In Drug Repurposing Market, by Deployment Mode, 2020-2034 (USD Billion)
    Table 112  Rest of Middle East & Africa: AI In Drug Repurposing Market, by End-user, 2020-2034 (USD Billion)
    Table 113 Latin America: AI In Drug Repurposing Market, by Drug Type, 2020-2034 (USD Billion)
    Table 114  Latin America: AI In Drug Repurposing Market, by Therapeutic Area, 2020-2034 (USD Billion)
    Table 115  Latin America: AI In Drug Repurposing Market, by Deployment Mode, 2020-2034 (USD Billion)
    Table 116  Latin America: AI In Drug Repurposing Market, by End-user, 2020-2034 (USD Billion)
    Table 117  Mexico: AI In Drug Repurposing Market, by Drug Type, 2020-2034 (USD Billion)
    Table 118  Mexico: AI In Drug Repurposing Market, by Therapeutic Area, 2020-2034 (USD Billion)
    Table 119  Mexico: AI In Drug Repurposing Market, by Deployment Mode, 2020-2034 (USD Billion)
    Table 120  Mexico: AI In Drug Repurposing Market, by End-user, 2020-2034 (USD Billion)
    Table 121  Brazil: AI In Drug Repurposing Market, by Drug Type, 2020-2034 (USD Billion)
    Table 122  Brazil: AI In Drug Repurposing Market, by Therapeutic Area, 2020-2034 (USD Billion)
    Table 123  Brazil: AI In Drug Repurposing Market, by Deployment Mode, 2020-2034 (USD Billion)
    Table 124  Brazil: AI In Drug Repurposing Market, by End-user, 2020-2034 (USD Billion)
    Table 125   Argentina: AI In Drug Repurposing Market, by Drug Type, 2020-2034 (USD Billion)
    Table 126  Argentina: AI In Drug Repurposing Market, by Therapeutic Area, 2020-2034 (USD Billion)
    Table 127  Argentina: AI In Drug Repurposing Market, by Deployment Mode, 2020-2034 (USD Billion)
    Table 128  Argentina: AI In Drug Repurposing Market, by End-user, 2020-2034 (USD Billion)
    Table 129 Rest of Latin America: AI In Drug Repurposing Market, by Drug Type, 2020-2034 (USD Billion) 
    Table 130  Rest of Latin America: AI In Drug Repurposing Market, by Therapeutic Area, 2020-2034 (USD Billion)
    Table 131  Rest of Latin America: AI In Drug Repurposing Market, by Deployment Mode, 2020-2034 (USD Billion)
    Table 132  Rest of Latin America: AI In Drug Repurposing Market, by End-user, 2020-2034 (USD Billion) 

    List of Figures:

    Figure 1. Global AI In Drug Repurposing Market, 2020-2034 (USD Billion)
    Figure 2. Integrated Ecosystem
    Figure 3. Research Methodology: Top-Down & Bottom-Up Price
    Figure 4. Market by Geography
    Figure 5. Porter’s Five Forces
    Figure 6. Market by Drug Type
    Figure 7. Global AI In Drug Repurposing Market, by Drug Type, 2024 & 2034 (USD Billion)
    Figure 8. Market by Therapeutic Area
    Figure 9. Global AI In Drug Repurposing Market, by Therapeutic Area, 2024 & 2034 (USD Billion)
    Figure 10.  Market by Deployment Mode
    Figure 11.  Global AI In Drug Repurposing Market, by Deployment Mode, 2024 & 2034 (USD Billion)
    Figure 12.  Market by End-user
    Figure 13.  Global AI In Drug Repurposing Market, by End-user, 2024 & 2034 (USD Billion)